The #CCTG PR.21 secondary analysis presented at #ASCO26 explores treatment sequencing in advanced prostate cancer. Results support both therapies as treatment options and may help clinicians make more personalized treatment decisions based on patient preferences. buff.ly/DQLTfTB
